All In Biotech

Drug Trial Radar · NCT05052996

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

A Phase 2 Randomized, Open-Label, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingRandomized with 142 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

142

Actual

Start

Oct 5, 2021

Primary completion

Dec 19, 2023

Study completion Mar 2028

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Sep 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologically suppressed people with HIV (PWH) at Week 24.

Conditions

  • HIV-1 Infection

Interventions

  • ISLDrug

    Capsules administered orally without regard to food

  • LENDrug

    Tablets administered orally without regard to food

  • B/F/TAFDrug

    Tablets administered orally without regard to food

  • ISL/LEN FDCDrug

    Tablets administered orally without regard to food

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With HIV-1 RNA ≥ 50 Copies/mL at Week 24 as Determined by the US Food and Drug Administration (FDA)-Defined Snapshot AlgorithmTime frame: Week 24

Locations

44 sites in 1 country. Site status is shown where the registry gives one.

  • Pacific Oaks Medical Group

    Beverly Hills, California

  • Ruane Clinical Research Group, Inc

    Los Angeles, California

  • Mills Clinical Research

    Los Angeles, California

  • Hoag Medical Group - Newport Beach

    Newport Beach, California

  • BIOS Clinical Research

    Palm Springs, California

  • Optimus Medical Group

    San Francisco, California

  • Public Health Institute at Denver Health

    Denver, Colorado

  • Vivent Health

    Denver, Colorado

  • Washington Health Institute

    Washington D.C., District of Columbia

  • The George Washington University Medical Faculty Associates Inc.

    Washington D.C., District of Columbia

  • CAN Community Health Care, Inc.

    Fort Lauderdale, Florida

  • Midway Immunology and Research Center

    Ft. Pierce, Florida

  • JEM Research Institute

    Lake Worth, Florida

  • Schiff Center for Liver Diseases/University of Miami

    Miami, Florida

  • Floridian Clinical Research

    Miami Lakes, Florida

  • Orlando Immunology Center

    Orlando, Florida

  • Emory University Hospital Midtown Infectious Disease Clinic

    Atlanta, Georgia

  • Atlanta ID Group, PC

    Atlanta, Georgia

  • Metro Infectious Disease Consultants

    Decatur, Georgia

  • Chatham County Health Department

    Savannah, Georgia

  • John A. Burns School of Medicine, University of Hawaii Clinics at Kaka'ako

    Honolulu, Hawaii

  • Howard Brown Health Center

    Chicago, Illinois

  • Northstar Healthcare

    Chicago, Illinois

  • Indiana CTSI Clinical Research Center

    Indianapolis, Indiana

  • Boston Medical Center

    Boston, Massachusetts

  • AccessHealth MA

    Boston, Massachusetts

  • Be Well Medical Center

    Berkley, Michigan

  • Hennepin Healthcare HCMC

    New Brighton, Minnesota

  • Southampton Healthcare, Inc.

    St Louis, Missouri

  • Huntridge Family Clinic

    Las Vegas, Nevada

  • ID Care

    Hillsborough, New Jersey

  • AXCES Research Group

    Santa Fe, New Mexico

  • New York-Presbyterian Queens

    Flushing, New York

  • Jacobi Medical Center

    The Bronx, New York

  • NC TraCS Institute - CTRC: University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Penn Medicine: Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Philadelphia FIGHT Community Health Centers

    Philadelphia, Pennsylvania

  • Central Texas Clinical Research, LLC

    Austin, Texas

  • AIDS Arms Inc

    Dallas, Texas

  • North Texas Infectious Diseases Consultants, P.A.

    Dallas, Texas

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.